Year: 2025
Type: article
Abstract: Generalized Anxiety Disorder (GAD) is a prevalent and often chronic psychiatric condition characterized by excessive, uncontrollable worry occurring across multiple domains for at least six months [1]. Despite its high burden, GAD remains underdiagnosed and undertreated [2]. This article provides a comprehensive overview of GAD: its epidemiology and clinical features, underlying mechanisms (cognitive, biological, neural, interpersonal), diagnostic issues, and current treatment paradigms (psychological, pharmacological, digital) [3,4]. We review and compare findings from key studies, highlight areas of agreement and divergence, and point to gaps for future research [5,6]. In conclusion, while evidence supports the efficacy of cognitive-behavioural therapy (CBT) and first‐line pharmacotherapy (SSRIs/SNRIs) [2,7], emerging modalities such as digital interventions and novel biological targets warrant further investigation to improve outcomes and reduce the care gap [6,8].
Source: Современная наука и исследования
Language: English
Subfield: Experimental and Cognitive Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: diamond
OpenAlex ID: W7103881954